This opportunity is closed. Its page stays for reference.
Similar open opportunities
61. Generika-Ausschreibung
At a glance
spectrumK GmbH is procuring Pharmaceutical products (CPV 33600000) in Berlin (DE300). It is divided into 44 lots and is closed. The notice gives 21 September 2026, 10:00 (UTC+02:00) as the deadline. Procedure type: Open.
From the notice
Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V
Key facts
Each fact is from the official notice, last checked 10 November 2026, 01:31 (UTC+01:00).
- Status
- ClosedOfficial notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- Deadline
- Deadline passed (50 days ago)Official notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- Buyer
- spectrumK GmbH, Berlin, DEOfficial notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- Place of performance
- Berlin (DE300)Official notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- Main CPV
- Pharmaceutical products (CPV 33600000)Official notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- Procedure
- OpenOfficial notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- Lots
- 44Official notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
- First published
- 22 July 2026, 15:30 (UTC+02:00)Official notice · checked 10 Nov 2026, 01:31 (UTC+01:00)
Fact sheet

Lots (44)
Lot LOT-0001: Fachlos 1001 - A03AA04 - Mebeverin
Mebeverin; 1 Zuschlag
Lot LOT-0002: Fachlos 1002 - A04AA05 - Palonosetron
Palonosetron; 1 Zuschlag
Lot LOT-0003: Fachlos 1003 - A06AD11 - Lactulose
Lactulose; 1 Zuschlag
Lot LOT-0004: Fachlos 1004 - A07EC02 - Mesalazin
Mesalazin; 2 Zuschläge
Lot LOT-0005: Fachlos 1005 - B01AC06 - Acetylsalicylsäure
Acetylsalicylsäure; 1 Zuschlag
Lot LOT-0006: Fachlos 1006 - B01AF01 - Rivaroxaban
Rivaroxaban; 3 Zuschläge
Lot LOT-0007: Fachlos 1007 - C01EB17 - Ivabradin
Ivabradin; 3 Zuschläge
Lot LOT-0008: Fachlos 1008 - C09CA04 - Irbesartan
Irbesartan; 1 Zuschlag
Lot LOT-0009: Fachlos 1009 - C09DB07 - Candesartan und Amlodipin
Amlodipin, Candesartan; 2 Zuschläge
Lot LOT-0010: Fachlos 1010 - C10AX09 - Ezetimib
Ezetimib; 3 Zuschläge
Lot LOT-0011: Fachlos 1011 - C10BA06 - Rosuvastatin und Ezetimib
Ezetimib, Rosuvastatin; 3 Zuschläge
Lot LOT-0012: Fachlos 1012 - D01AE14 - Ciclopirox
Ciclopirox; 1 Zuschlag
Lot LOT-0013: Fachlos 1013 - D07AA02 - Hydrocortison
Hydrocortison; 1 Zuschlag
Lot LOT-0014: Fachlos 1014 - G03AA07 - Levonorgestrel und Ethinylestradiol
Ethinylestradiol, Levonorgestrel; 3 Zuschläge
Lot LOT-0015: Fachlos 1015 - G03AA07 - Levonorgestrel und Ethinylestradiol
Ethinylestradiol, Levonorgestrel; 1 Zuschlag
Lot LOT-0016: Fachlos 1016 - G03AA09 - Desogestrel und Ethinylestradiol
Desogestrel, Ethinylestradiol; 1 Zuschlag
Lot LOT-0017: Fachlos 1017 - G03AA09 - Desogestrel und Ethinylestradiol
Desogestrel, Ethinylestradiol; 1 Zuschlag
Lot LOT-0018: Fachlos 1018 - G04BE03 - Sildenafil
Sildenafil; 3 Zuschläge
Lot LOT-0019: Fachlos 1019 - G04CA52 - Tamsulosin und Dutasterid
Dutasterid, Tamsulosin; 3 Zuschläge
Lot LOT-0020: Fachlos 1020 - H02AB09 - Hydrocortison
Hydrocortison; 3 Zuschläge
Lot LOT-0021: Fachlos 1021 - H03BB01 - Carbimazol
Carbimazol; 1 Zuschlag
Lot LOT-0022: Fachlos 1022 - J05AG01 - Nevirapin
Nevirapin; 1 Zuschlag
Lot LOT-0023: Fachlos 1023 - J05AR02 - Lamivudin und Abacavir
Abacavir, Lamivudin; 1 Zuschlag
Lot LOT-0024: Fachlos 1024 - J05AR03 - Tenofovirdisoproxil und Emtricitabin
Emtricitabin, Tenofovir disoproxil; 3 Zuschläge
Lot LOT-0025: Fachlos 1025 - L01EB02 - Erlotinib
Erlotinib; 1 Zuschlag
Lot LOT-0026: Fachlos 1026 - L01EX09 - Nintedanib
Nintedanib; 3 Zuschläge
Lot LOT-0027: Fachlos 1027 - L01EX09 - Nintedanib
Nintedanib; 1 Zuschlag
Lot LOT-0028: Fachlos 1028 - L02BA03 - Fulvestrant
Fulvestrant; 3 Zuschläge
Lot LOT-0029: Fachlos 1029 - M01AC06 - Meloxicam
Meloxicam; 1 Zuschlag
Lot LOT-0030: Fachlos 1030 - M01AH01 - Celecoxib
Celecoxib; 3 Zuschläge
Lot LOT-0031: Fachlos 1031 - N03AD01 - Ethosuximid
Ethosuximid; 1 Zuschlag
Lot LOT-0032: Fachlos 1032 - N03AX03 - Sultiam
Sultiam; 1 Zuschlag
Lot LOT-0033: Fachlos 1033 - N06AF04 - Tranylcypromin
Tranylcypromin; 1 Zuschlag
Lot LOT-0034: Fachlos 1034 - N06AX05 - Trazodon
Trazodon; 1 Zuschlag
Lot LOT-0035: Fachlos 1035 - N06BA12 - Lisdexamfetamin
Dexamfetamin; 2 Zuschläge
Lot LOT-0036: Fachlos 1036 - N07CA52 - Cinnarizin, Kombinationen
Cinnarizin, Dimenhydrinat; 2 Zuschläge
Lot LOT-0037: Fachlos 1037 - R01AD05 - Budesonid
Budesonid; 1 Zuschlag
Lot LOT-0038: Fachlos 1038 - R01AD58 - Fluticason, Kombinationen
Azelastin, Fluticason 17-propionat; 1 Zuschlag
Lot LOT-0039: Fachlos 1039 - R03AK06 - Salmeterol und Fluticason
Fluticason 17-propionat, Salmeterol; 1 Zuschlag
Lot LOT-0040: Fachlos 1040 - R03AK06 - Salmeterol und Fluticason
Fluticason 17-propionat, Salmeterol; 3 Zuschläge
Lot LOT-0041: Fachlos 1041 - R03BB04 - Tiotropiumbromid
Tiotropium-Kation; 2 Zuschläge
Lot LOT-0042: Fachlos 1042 - R05CB01 - Acetylcystein
Acetylcystein; 1 Zuschlag
Lot LOT-0043: Fachlos 1043 - S01ED51 - Timolol, Kombinationen
Bimatoprost, Timolol; 2 Zuschläge
Lot LOT-0044: Fachlos 1044 - S01ED51 - Timolol, Kombinationen
Bimatoprost, Timolol; 1 Zuschlag
Timeline
- 22 July 2026, 15:30 (UTC+02:00): Original notice Notice, version 01 (Contract or concession notice – standard regime). Official notice
Buyer and place
Buyer
spectrumK GmbH
Berlin, DE
Place of performance
- Berlin (DE300)
Classification
CPV codes
- 33600000: Pharmaceutical products
NUTS regions
- DE300: Berlin
Official documents
No documents found in the indexed notice.
Questions and answers
When is the deadline?
The official notice gives 21 September 2026, 10:00 (UTC+02:00) as the deadline.
Who is the buyer?
spectrumK GmbH, Berlin, DE.
What is being procured (CPV)?
Pharmaceutical products (CPV 33600000).
Where is the work performed (NUTS)?
Berlin (DE300).
Is it divided into lots?
Yes, into 44 lots: Fachlos 1001 - A03AA04 - Mebeverin, Fachlos 1002 - A04AA05 - Palonosetron, Fachlos 1003 - A06AD11 - Lactulose, Fachlos 1004 - A07EC02 - Mesalazin, Fachlos 1005 - B01AC06 - Acetylsalicylsäure, Fachlos 1006 - B01AF01 - Rivaroxaban, Fachlos 1007 - C01EB17 - Ivabradin, Fachlos 1008 - C09CA04 - Irbesartan and 36 more.
Which procedure is used?
Open.
How do I submit a bid?
On the official notice or the portal it names. Inteliwert does not submit bids. Official notice
Am I eligible?
Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice
More from this buyer
Other published opportunities of this buyer in the indexed notices, open ones first.
-
OpenTender
62. Generika-Ausschreibung
Last checked 4 Nov 2026, 15:10 (UTC+01:00)Official notice -
OpenTender
Rahmenvertrag Arbeitnehmerüberlassung
Last checked 8 Nov 2026, 14:31 (UTC+01:00)Official notice -
ClosedTender
Rahmenvertrag Cloud IP-Telefonie und Kommunikationslösung
Last checked 7 Nov 2026, 15:31 (UTC+01:00)Official notice -
AwardedTender
Bereitstellung eines Personalmanagementsystems
Last checked 9 Nov 2026, 07:31 (UTC+01:00)Official notice
Source
- Publisher
- Bekanntmachungsservice
- Licence
- CC0 1.0
- Last checked
- 10 November 2026, 01:31 (UTC+01:00)
The official notice is authoritative. Inteliwert shows what the notice states and links to it.